Cochlear
Organization
An Australian medical-device company that develops and sells implantable hearing solutions, including cochlear implants.
What experts have said about Cochlear
5 statements · 3 positive · 2 negative
Cochlear became attractive after its sharp decline and subsequently rallied 50%.
“We bought it. It's already rallied 50%.”
Open the episode · Riding the rebound in CSL, Cochlear and finding the next opportunityListen at 17:19
Cochlear shares rose 7.5%.
“Cochlear is up seven and a half percent.”
Open the episode · BHP Rises, Tokyo Electron Down, Alibaba UpListen at 1:33
Cochlear appears to be improving through greater operational efficiency.
“this long suffering maker of hearing aids finally seems to be turning the corner just by getting more operational efficiency out of the company”
Open the episode · BHP Rises, Tokyo Electron Down, Alibaba UpListen at 1:35
Cochlear’s price increases shifted demand toward competitors.
“demand kind of shifted over to them over the past 6 months or a year or so.”
Open the episode · Stock Take: Eight Results That MatterListen at 7:54
Damaged pricing power could undermine Cochlear’s investment case.
“if that is damaged, then it can be Yeah, that, that, that could really ruin its kind of buy case”
Open the episode · Stock Take: Eight Results That MatterListen at 9:29
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
2 episodes featuring Cochlear
The Rules of Investing
Value investors find opportunity in Australia’s fallen angels
The discussion tests whether depressed expectations and market volatility are creating durable opportunities—or simply disguising structural risks.
Sep 18, 2026 · 42 min
Stock Take
Eight stocks face defining tests this reporting season
The episode identifies the operational milestones, competitive threats and valuation questions that could reshape eight investment cases.
Aug 6, 2026 · 41 min